Global Exosome Detection and Diagnosis Supply, Demand and Key Producers, 2024-2030
The global Exosome Detection and Diagnosis market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.
This report studies the global Exosome Detection and Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Exosome Detection and Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosome Detection and Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Exosome Detection and Diagnosis total market, 2019-2030, (USD Million)
Global Exosome Detection and Diagnosis total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Exosome Detection and Diagnosis total market, key domestic companies and share, (USD Million)
Global Exosome Detection and Diagnosis revenue by player and market share 2019-2024, (USD Million)
Global Exosome Detection and Diagnosis total market by Type, CAGR, 2019-2030, (USD Million)
Global Exosome Detection and Diagnosis total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Exosome Detection and Diagnosis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN, Lonza, NX Pharmagen, NanoSomiX, Miltenyi Biotech and Norgen Biotek, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Exosome Detection and Diagnosis market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Exosome Detection and Diagnosis Market, By Region:
1. How big is the global Exosome Detection and Diagnosis market?
2. What is the demand of the global Exosome Detection and Diagnosis market?
3. What is the year over year growth of the global Exosome Detection and Diagnosis market?
4. What is the total value of the global Exosome Detection and Diagnosis market?
5. Who are the major players in the global Exosome Detection and Diagnosis market?
Exosomes are small extracellular vesicles released by various cells into the extracellular space. They contain proteins, lipids, and nucleic acids, playing a role in intercellular communication.
This report studies the global Exosome Detection and Diagnosis demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Exosome Detection and Diagnosis, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Exosome Detection and Diagnosis that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Exosome Detection and Diagnosis total market, 2019-2030, (USD Million)
Global Exosome Detection and Diagnosis total market by region & country, CAGR, 2019-2030, (USD Million)
U.S. VS China: Exosome Detection and Diagnosis total market, key domestic companies and share, (USD Million)
Global Exosome Detection and Diagnosis revenue by player and market share 2019-2024, (USD Million)
Global Exosome Detection and Diagnosis total market by Type, CAGR, 2019-2030, (USD Million)
Global Exosome Detection and Diagnosis total market by Application, CAGR, 2019-2030, (USD Million).
This reports profiles major players in the global Exosome Detection and Diagnosis market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher Scientific, Bio-Techne, System Biosciences, QIAGEN, Lonza, NX Pharmagen, NanoSomiX, Miltenyi Biotech and Norgen Biotek, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Exosome Detection and Diagnosis market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Exosome Detection and Diagnosis Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Kits & Reagents
- Instruments
- Services
- Cancers
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Other
- Thermo Fisher Scientific
- Bio-Techne
- System Biosciences
- QIAGEN
- Lonza
- NX Pharmagen
- NanoSomiX
- Miltenyi Biotech
- Norgen Biotek
- AMSBio
- Aethlon Medical
- Anjarium Biosciences
- Ciloa
- InnovaPrep
- Creative Medical Technologies
- ILIAS Biologics
- Unchained Labs
- Rion
- Cell Guidance System
- INOVIQ
- Danaher
- Exopharm
- Everzom
- RoosterBio
- Creative Biolabs
1. How big is the global Exosome Detection and Diagnosis market?
2. What is the demand of the global Exosome Detection and Diagnosis market?
3. What is the year over year growth of the global Exosome Detection and Diagnosis market?
4. What is the total value of the global Exosome Detection and Diagnosis market?
5. Who are the major players in the global Exosome Detection and Diagnosis market?
1 SUPPLY SUMMARY
1.1 Exosome Detection and Diagnosis Introduction
1.2 World Exosome Detection and Diagnosis Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Exosome Detection and Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Exosome Detection and Diagnosis Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.3 China Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.4 Europe Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.5 Japan Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.6 South Korea Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.7 ASEAN Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.8 India Exosome Detection and Diagnosis Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Exosome Detection and Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Exosome Detection and Diagnosis Major Market Trends
2 DEMAND SUMMARY
2.1 World Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.2 World Exosome Detection and Diagnosis Consumption Value by Region
2.2.1 World Exosome Detection and Diagnosis Consumption Value by Region (2019-2024)
2.2.2 World Exosome Detection and Diagnosis Consumption Value Forecast by Region (2025-2030)
2.3 United States Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.4 China Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.5 Europe Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.6 Japan Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.7 South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.8 ASEAN Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.9 India Exosome Detection and Diagnosis Consumption Value (2019-2030)
3 WORLD EXOSOME DETECTION AND DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Exosome Detection and Diagnosis Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Exosome Detection and Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Exosome Detection and Diagnosis in 2023
3.2.3 Global Concentration Ratios (CR8) for Exosome Detection and Diagnosis in 2023
3.3 Exosome Detection and Diagnosis Company Evaluation Quadrant
3.4 Exosome Detection and Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Exosome Detection and Diagnosis Market: Region Footprint
3.4.2 Exosome Detection and Diagnosis Market: Company Product Type Footprint
3.4.3 Exosome Detection and Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Exosome Detection and Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Exosome Detection and Diagnosis Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Exosome Detection and Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Exosome Detection and Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Exosome Detection and Diagnosis Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Exosome Detection and Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Exosome Detection and Diagnosis Companies and Market Share, 2019-2024
4.3.1 United States Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
4.4 China Based Companies Exosome Detection and Diagnosis Revenue and Market Share, 2019-2024
4.4.1 China Based Exosome Detection and Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
4.5 Rest of World Based Exosome Detection and Diagnosis Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Exosome Detection and Diagnosis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Kits & Reagents
5.2.2 Instruments
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World Exosome Detection and Diagnosis Market Size by Type (2019-2024)
5.3.2 World Exosome Detection and Diagnosis Market Size by Type (2025-2030)
5.3.3 World Exosome Detection and Diagnosis Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Exosome Detection and Diagnosis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancers
6.2.2 Neurodegenerative Diseases
6.2.3 Cardiovascular Diseases
6.2.4 Infectious Diseases
6.2.5 Infectious Diseases
6.3 Market Segment by Application
6.3.1 World Exosome Detection and Diagnosis Market Size by Application (2019-2024)
6.3.2 World Exosome Detection and Diagnosis Market Size by Application (2025-2030)
6.3.3 World Exosome Detection and Diagnosis Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Services
7.1.4 Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne Exosome Detection and Diagnosis Product and Services
7.2.4 Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 System Biosciences
7.3.1 System Biosciences Details
7.3.2 System Biosciences Major Business
7.3.3 System Biosciences Exosome Detection and Diagnosis Product and Services
7.3.4 System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 System Biosciences Recent Developments/Updates
7.3.6 System Biosciences Competitive Strengths & Weaknesses
7.4 QIAGEN
7.4.1 QIAGEN Details
7.4.2 QIAGEN Major Business
7.4.3 QIAGEN Exosome Detection and Diagnosis Product and Services
7.4.4 QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 QIAGEN Recent Developments/Updates
7.4.6 QIAGEN Competitive Strengths & Weaknesses
7.5 Lonza
7.5.1 Lonza Details
7.5.2 Lonza Major Business
7.5.3 Lonza Exosome Detection and Diagnosis Product and Services
7.5.4 Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Lonza Recent Developments/Updates
7.5.6 Lonza Competitive Strengths & Weaknesses
7.6 NX Pharmagen
7.6.1 NX Pharmagen Details
7.6.2 NX Pharmagen Major Business
7.6.3 NX Pharmagen Exosome Detection and Diagnosis Product and Services
7.6.4 NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 NX Pharmagen Recent Developments/Updates
7.6.6 NX Pharmagen Competitive Strengths & Weaknesses
7.7 NanoSomiX
7.7.1 NanoSomiX Details
7.7.2 NanoSomiX Major Business
7.7.3 NanoSomiX Exosome Detection and Diagnosis Product and Services
7.7.4 NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 NanoSomiX Recent Developments/Updates
7.7.6 NanoSomiX Competitive Strengths & Weaknesses
7.8 Miltenyi Biotech
7.8.1 Miltenyi Biotech Details
7.8.2 Miltenyi Biotech Major Business
7.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Product and Services
7.8.4 Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Miltenyi Biotech Recent Developments/Updates
7.8.6 Miltenyi Biotech Competitive Strengths & Weaknesses
7.9 Norgen Biotek
7.9.1 Norgen Biotek Details
7.9.2 Norgen Biotek Major Business
7.9.3 Norgen Biotek Exosome Detection and Diagnosis Product and Services
7.9.4 Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Norgen Biotek Recent Developments/Updates
7.9.6 Norgen Biotek Competitive Strengths & Weaknesses
7.10 AMSBio
7.10.1 AMSBio Details
7.10.2 AMSBio Major Business
7.10.3 AMSBio Exosome Detection and Diagnosis Product and Services
7.10.4 AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 AMSBio Recent Developments/Updates
7.10.6 AMSBio Competitive Strengths & Weaknesses
7.11 Aethlon Medical
7.11.1 Aethlon Medical Details
7.11.2 Aethlon Medical Major Business
7.11.3 Aethlon Medical Exosome Detection and Diagnosis Product and Services
7.11.4 Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Aethlon Medical Recent Developments/Updates
7.11.6 Aethlon Medical Competitive Strengths & Weaknesses
7.12 Anjarium Biosciences
7.12.1 Anjarium Biosciences Details
7.12.2 Anjarium Biosciences Major Business
7.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Product and Services
7.12.4 Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Anjarium Biosciences Recent Developments/Updates
7.12.6 Anjarium Biosciences Competitive Strengths & Weaknesses
7.13 Ciloa
7.13.1 Ciloa Details
7.13.2 Ciloa Major Business
7.13.3 Ciloa Exosome Detection and Diagnosis Product and Services
7.13.4 Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Ciloa Recent Developments/Updates
7.13.6 Ciloa Competitive Strengths & Weaknesses
7.14 InnovaPrep
7.14.1 InnovaPrep Details
7.14.2 InnovaPrep Major Business
7.14.3 InnovaPrep Exosome Detection and Diagnosis Product and Services
7.14.4 InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 InnovaPrep Recent Developments/Updates
7.14.6 InnovaPrep Competitive Strengths & Weaknesses
7.15 Creative Medical Technologies
7.15.1 Creative Medical Technologies Details
7.15.2 Creative Medical Technologies Major Business
7.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Product and Services
7.15.4 Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Creative Medical Technologies Recent Developments/Updates
7.15.6 Creative Medical Technologies Competitive Strengths & Weaknesses
7.16 ILIAS Biologics
7.16.1 ILIAS Biologics Details
7.16.2 ILIAS Biologics Major Business
7.16.3 ILIAS Biologics Exosome Detection and Diagnosis Product and Services
7.16.4 ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 ILIAS Biologics Recent Developments/Updates
7.16.6 ILIAS Biologics Competitive Strengths & Weaknesses
7.17 Unchained Labs
7.17.1 Unchained Labs Details
7.17.2 Unchained Labs Major Business
7.17.3 Unchained Labs Exosome Detection and Diagnosis Product and Services
7.17.4 Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Unchained Labs Recent Developments/Updates
7.17.6 Unchained Labs Competitive Strengths & Weaknesses
7.18 Rion
7.18.1 Rion Details
7.18.2 Rion Major Business
7.18.3 Rion Exosome Detection and Diagnosis Product and Services
7.18.4 Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Rion Recent Developments/Updates
7.18.6 Rion Competitive Strengths & Weaknesses
7.19 Cell Guidance System
7.19.1 Cell Guidance System Details
7.19.2 Cell Guidance System Major Business
7.19.3 Cell Guidance System Exosome Detection and Diagnosis Product and Services
7.19.4 Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Cell Guidance System Recent Developments/Updates
7.19.6 Cell Guidance System Competitive Strengths & Weaknesses
7.20 INOVIQ
7.20.1 INOVIQ Details
7.20.2 INOVIQ Major Business
7.20.3 INOVIQ Exosome Detection and Diagnosis Product and Services
7.20.4 INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 INOVIQ Recent Developments/Updates
7.20.6 INOVIQ Competitive Strengths & Weaknesses
7.21 Danaher
7.21.1 Danaher Details
7.21.2 Danaher Major Business
7.21.3 Danaher Exosome Detection and Diagnosis Product and Services
7.21.4 Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 Danaher Recent Developments/Updates
7.21.6 Danaher Competitive Strengths & Weaknesses
7.22 Exopharm
7.22.1 Exopharm Details
7.22.2 Exopharm Major Business
7.22.3 Exopharm Exosome Detection and Diagnosis Product and Services
7.22.4 Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 Exopharm Recent Developments/Updates
7.22.6 Exopharm Competitive Strengths & Weaknesses
7.23 Everzom
7.23.1 Everzom Details
7.23.2 Everzom Major Business
7.23.3 Everzom Exosome Detection and Diagnosis Product and Services
7.23.4 Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 Everzom Recent Developments/Updates
7.23.6 Everzom Competitive Strengths & Weaknesses
7.24 RoosterBio
7.24.1 RoosterBio Details
7.24.2 RoosterBio Major Business
7.24.3 RoosterBio Exosome Detection and Diagnosis Product and Services
7.24.4 RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 RoosterBio Recent Developments/Updates
7.24.6 RoosterBio Competitive Strengths & Weaknesses
7.25 Creative Biolabs
7.25.1 Creative Biolabs Details
7.25.2 Creative Biolabs Major Business
7.25.3 Creative Biolabs Exosome Detection and Diagnosis Product and Services
7.25.4 Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 Creative Biolabs Recent Developments/Updates
7.25.6 Creative Biolabs Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Exosome Detection and Diagnosis Industry Chain
8.2 Exosome Detection and Diagnosis Upstream Analysis
8.3 Exosome Detection and Diagnosis Midstream Analysis
8.4 Exosome Detection and Diagnosis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Exosome Detection and Diagnosis Introduction
1.2 World Exosome Detection and Diagnosis Market Size & Forecast (2019 & 2023 & 2030)
1.3 World Exosome Detection and Diagnosis Total Market by Region (by Headquarter Location)
1.3.1 World Exosome Detection and Diagnosis Market Size by Region (2019-2030), (by Headquarter Location)
1.3.2 United States Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.3 China Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.4 Europe Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.5 Japan Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.6 South Korea Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.7 ASEAN Exosome Detection and Diagnosis Market Size (2019-2030)
1.3.8 India Exosome Detection and Diagnosis Market Size (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Exosome Detection and Diagnosis Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Exosome Detection and Diagnosis Major Market Trends
2 DEMAND SUMMARY
2.1 World Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.2 World Exosome Detection and Diagnosis Consumption Value by Region
2.2.1 World Exosome Detection and Diagnosis Consumption Value by Region (2019-2024)
2.2.2 World Exosome Detection and Diagnosis Consumption Value Forecast by Region (2025-2030)
2.3 United States Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.4 China Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.5 Europe Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.6 Japan Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.7 South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.8 ASEAN Exosome Detection and Diagnosis Consumption Value (2019-2030)
2.9 India Exosome Detection and Diagnosis Consumption Value (2019-2030)
3 WORLD EXOSOME DETECTION AND DIAGNOSIS COMPANIES COMPETITIVE ANALYSIS
3.1 World Exosome Detection and Diagnosis Revenue by Player (2019-2024)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Exosome Detection and Diagnosis Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Exosome Detection and Diagnosis in 2023
3.2.3 Global Concentration Ratios (CR8) for Exosome Detection and Diagnosis in 2023
3.3 Exosome Detection and Diagnosis Company Evaluation Quadrant
3.4 Exosome Detection and Diagnosis Market: Overall Company Footprint Analysis
3.4.1 Exosome Detection and Diagnosis Market: Region Footprint
3.4.2 Exosome Detection and Diagnosis Market: Company Product Type Footprint
3.4.3 Exosome Detection and Diagnosis Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Exosome Detection and Diagnosis Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Exosome Detection and Diagnosis Market Size Comparison (2019 & 2023 & 2030) (by Headquarter Location)
4.1.2 United States VS China: Exosome Detection and Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
4.2 United States Based Companies VS China Based Companies: Exosome Detection and Diagnosis Consumption Value Comparison
4.2.1 United States VS China: Exosome Detection and Diagnosis Consumption Value Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Exosome Detection and Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
4.3 United States Based Exosome Detection and Diagnosis Companies and Market Share, 2019-2024
4.3.1 United States Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
4.4 China Based Companies Exosome Detection and Diagnosis Revenue and Market Share, 2019-2024
4.4.1 China Based Exosome Detection and Diagnosis Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
4.5 Rest of World Based Exosome Detection and Diagnosis Companies and Market Share, 2019-2024
4.5.1 Rest of World Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Exosome Detection and Diagnosis Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Kits & Reagents
5.2.2 Instruments
5.2.3 Services
5.3 Market Segment by Type
5.3.1 World Exosome Detection and Diagnosis Market Size by Type (2019-2024)
5.3.2 World Exosome Detection and Diagnosis Market Size by Type (2025-2030)
5.3.3 World Exosome Detection and Diagnosis Market Size Market Share by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Exosome Detection and Diagnosis Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Cancers
6.2.2 Neurodegenerative Diseases
6.2.3 Cardiovascular Diseases
6.2.4 Infectious Diseases
6.2.5 Infectious Diseases
6.3 Market Segment by Application
6.3.1 World Exosome Detection and Diagnosis Market Size by Application (2019-2024)
6.3.2 World Exosome Detection and Diagnosis Market Size by Application (2025-2030)
6.3.3 World Exosome Detection and Diagnosis Market Size by Application (2019-2030)
7 COMPANY PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Details
7.1.2 Thermo Fisher Scientific Major Business
7.1.3 Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Services
7.1.4 Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.1.5 Thermo Fisher Scientific Recent Developments/Updates
7.1.6 Thermo Fisher Scientific Competitive Strengths & Weaknesses
7.2 Bio-Techne
7.2.1 Bio-Techne Details
7.2.2 Bio-Techne Major Business
7.2.3 Bio-Techne Exosome Detection and Diagnosis Product and Services
7.2.4 Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.2.5 Bio-Techne Recent Developments/Updates
7.2.6 Bio-Techne Competitive Strengths & Weaknesses
7.3 System Biosciences
7.3.1 System Biosciences Details
7.3.2 System Biosciences Major Business
7.3.3 System Biosciences Exosome Detection and Diagnosis Product and Services
7.3.4 System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.3.5 System Biosciences Recent Developments/Updates
7.3.6 System Biosciences Competitive Strengths & Weaknesses
7.4 QIAGEN
7.4.1 QIAGEN Details
7.4.2 QIAGEN Major Business
7.4.3 QIAGEN Exosome Detection and Diagnosis Product and Services
7.4.4 QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.4.5 QIAGEN Recent Developments/Updates
7.4.6 QIAGEN Competitive Strengths & Weaknesses
7.5 Lonza
7.5.1 Lonza Details
7.5.2 Lonza Major Business
7.5.3 Lonza Exosome Detection and Diagnosis Product and Services
7.5.4 Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.5.5 Lonza Recent Developments/Updates
7.5.6 Lonza Competitive Strengths & Weaknesses
7.6 NX Pharmagen
7.6.1 NX Pharmagen Details
7.6.2 NX Pharmagen Major Business
7.6.3 NX Pharmagen Exosome Detection and Diagnosis Product and Services
7.6.4 NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.6.5 NX Pharmagen Recent Developments/Updates
7.6.6 NX Pharmagen Competitive Strengths & Weaknesses
7.7 NanoSomiX
7.7.1 NanoSomiX Details
7.7.2 NanoSomiX Major Business
7.7.3 NanoSomiX Exosome Detection and Diagnosis Product and Services
7.7.4 NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.7.5 NanoSomiX Recent Developments/Updates
7.7.6 NanoSomiX Competitive Strengths & Weaknesses
7.8 Miltenyi Biotech
7.8.1 Miltenyi Biotech Details
7.8.2 Miltenyi Biotech Major Business
7.8.3 Miltenyi Biotech Exosome Detection and Diagnosis Product and Services
7.8.4 Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.8.5 Miltenyi Biotech Recent Developments/Updates
7.8.6 Miltenyi Biotech Competitive Strengths & Weaknesses
7.9 Norgen Biotek
7.9.1 Norgen Biotek Details
7.9.2 Norgen Biotek Major Business
7.9.3 Norgen Biotek Exosome Detection and Diagnosis Product and Services
7.9.4 Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.9.5 Norgen Biotek Recent Developments/Updates
7.9.6 Norgen Biotek Competitive Strengths & Weaknesses
7.10 AMSBio
7.10.1 AMSBio Details
7.10.2 AMSBio Major Business
7.10.3 AMSBio Exosome Detection and Diagnosis Product and Services
7.10.4 AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.10.5 AMSBio Recent Developments/Updates
7.10.6 AMSBio Competitive Strengths & Weaknesses
7.11 Aethlon Medical
7.11.1 Aethlon Medical Details
7.11.2 Aethlon Medical Major Business
7.11.3 Aethlon Medical Exosome Detection and Diagnosis Product and Services
7.11.4 Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.11.5 Aethlon Medical Recent Developments/Updates
7.11.6 Aethlon Medical Competitive Strengths & Weaknesses
7.12 Anjarium Biosciences
7.12.1 Anjarium Biosciences Details
7.12.2 Anjarium Biosciences Major Business
7.12.3 Anjarium Biosciences Exosome Detection and Diagnosis Product and Services
7.12.4 Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.12.5 Anjarium Biosciences Recent Developments/Updates
7.12.6 Anjarium Biosciences Competitive Strengths & Weaknesses
7.13 Ciloa
7.13.1 Ciloa Details
7.13.2 Ciloa Major Business
7.13.3 Ciloa Exosome Detection and Diagnosis Product and Services
7.13.4 Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.13.5 Ciloa Recent Developments/Updates
7.13.6 Ciloa Competitive Strengths & Weaknesses
7.14 InnovaPrep
7.14.1 InnovaPrep Details
7.14.2 InnovaPrep Major Business
7.14.3 InnovaPrep Exosome Detection and Diagnosis Product and Services
7.14.4 InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.14.5 InnovaPrep Recent Developments/Updates
7.14.6 InnovaPrep Competitive Strengths & Weaknesses
7.15 Creative Medical Technologies
7.15.1 Creative Medical Technologies Details
7.15.2 Creative Medical Technologies Major Business
7.15.3 Creative Medical Technologies Exosome Detection and Diagnosis Product and Services
7.15.4 Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.15.5 Creative Medical Technologies Recent Developments/Updates
7.15.6 Creative Medical Technologies Competitive Strengths & Weaknesses
7.16 ILIAS Biologics
7.16.1 ILIAS Biologics Details
7.16.2 ILIAS Biologics Major Business
7.16.3 ILIAS Biologics Exosome Detection and Diagnosis Product and Services
7.16.4 ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.16.5 ILIAS Biologics Recent Developments/Updates
7.16.6 ILIAS Biologics Competitive Strengths & Weaknesses
7.17 Unchained Labs
7.17.1 Unchained Labs Details
7.17.2 Unchained Labs Major Business
7.17.3 Unchained Labs Exosome Detection and Diagnosis Product and Services
7.17.4 Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.17.5 Unchained Labs Recent Developments/Updates
7.17.6 Unchained Labs Competitive Strengths & Weaknesses
7.18 Rion
7.18.1 Rion Details
7.18.2 Rion Major Business
7.18.3 Rion Exosome Detection and Diagnosis Product and Services
7.18.4 Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.18.5 Rion Recent Developments/Updates
7.18.6 Rion Competitive Strengths & Weaknesses
7.19 Cell Guidance System
7.19.1 Cell Guidance System Details
7.19.2 Cell Guidance System Major Business
7.19.3 Cell Guidance System Exosome Detection and Diagnosis Product and Services
7.19.4 Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.19.5 Cell Guidance System Recent Developments/Updates
7.19.6 Cell Guidance System Competitive Strengths & Weaknesses
7.20 INOVIQ
7.20.1 INOVIQ Details
7.20.2 INOVIQ Major Business
7.20.3 INOVIQ Exosome Detection and Diagnosis Product and Services
7.20.4 INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.20.5 INOVIQ Recent Developments/Updates
7.20.6 INOVIQ Competitive Strengths & Weaknesses
7.21 Danaher
7.21.1 Danaher Details
7.21.2 Danaher Major Business
7.21.3 Danaher Exosome Detection and Diagnosis Product and Services
7.21.4 Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.21.5 Danaher Recent Developments/Updates
7.21.6 Danaher Competitive Strengths & Weaknesses
7.22 Exopharm
7.22.1 Exopharm Details
7.22.2 Exopharm Major Business
7.22.3 Exopharm Exosome Detection and Diagnosis Product and Services
7.22.4 Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.22.5 Exopharm Recent Developments/Updates
7.22.6 Exopharm Competitive Strengths & Weaknesses
7.23 Everzom
7.23.1 Everzom Details
7.23.2 Everzom Major Business
7.23.3 Everzom Exosome Detection and Diagnosis Product and Services
7.23.4 Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.23.5 Everzom Recent Developments/Updates
7.23.6 Everzom Competitive Strengths & Weaknesses
7.24 RoosterBio
7.24.1 RoosterBio Details
7.24.2 RoosterBio Major Business
7.24.3 RoosterBio Exosome Detection and Diagnosis Product and Services
7.24.4 RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.24.5 RoosterBio Recent Developments/Updates
7.24.6 RoosterBio Competitive Strengths & Weaknesses
7.25 Creative Biolabs
7.25.1 Creative Biolabs Details
7.25.2 Creative Biolabs Major Business
7.25.3 Creative Biolabs Exosome Detection and Diagnosis Product and Services
7.25.4 Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024)
7.25.5 Creative Biolabs Recent Developments/Updates
7.25.6 Creative Biolabs Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Exosome Detection and Diagnosis Industry Chain
8.2 Exosome Detection and Diagnosis Upstream Analysis
8.3 Exosome Detection and Diagnosis Midstream Analysis
8.4 Exosome Detection and Diagnosis Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Exosome Detection and Diagnosis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Exosome Detection and Diagnosis Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Exosome Detection and Diagnosis Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Exosome Detection and Diagnosis Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Exosome Detection and Diagnosis Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Exosome Detection and Diagnosis Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Exosome Detection and Diagnosis Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Exosome Detection and Diagnosis Players in 2023
Table 12. World Exosome Detection and Diagnosis Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Exosome Detection and Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Exosome Detection and Diagnosis Player
Table 15. Exosome Detection and Diagnosis Market: Company Product Type Footprint
Table 16. Exosome Detection and Diagnosis Market: Company Product Application Footprint
Table 17. Exosome Detection and Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Exosome Detection and Diagnosis Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Exosome Detection and Diagnosis Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 23. China Based Exosome Detection and Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 26. Rest of World Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 29. World Exosome Detection and Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Exosome Detection and Diagnosis Market Size by Type (2019-2024) & (USD Million)
Table 31. World Exosome Detection and Diagnosis Market Size by Type (2025-2030) & (USD Million)
Table 32. World Exosome Detection and Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Exosome Detection and Diagnosis Market Size by Application (2019-2024) & (USD Million)
Table 34. World Exosome Detection and Diagnosis Market Size by Application (2025-2030) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Services
Table 38. Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Bio-Techne Basic Information, Area Served and Competitors
Table 42. Bio-Techne Major Business
Table 43. Bio-Techne Exosome Detection and Diagnosis Product and Services
Table 44. Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Bio-Techne Recent Developments/Updates
Table 46. Bio-Techne Competitive Strengths & Weaknesses
Table 47. System Biosciences Basic Information, Area Served and Competitors
Table 48. System Biosciences Major Business
Table 49. System Biosciences Exosome Detection and Diagnosis Product and Services
Table 50. System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. System Biosciences Recent Developments/Updates
Table 52. System Biosciences Competitive Strengths & Weaknesses
Table 53. QIAGEN Basic Information, Area Served and Competitors
Table 54. QIAGEN Major Business
Table 55. QIAGEN Exosome Detection and Diagnosis Product and Services
Table 56. QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. QIAGEN Recent Developments/Updates
Table 58. QIAGEN Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Area Served and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Exosome Detection and Diagnosis Product and Services
Table 62. Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. NX Pharmagen Basic Information, Area Served and Competitors
Table 66. NX Pharmagen Major Business
Table 67. NX Pharmagen Exosome Detection and Diagnosis Product and Services
Table 68. NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. NX Pharmagen Recent Developments/Updates
Table 70. NX Pharmagen Competitive Strengths & Weaknesses
Table 71. NanoSomiX Basic Information, Area Served and Competitors
Table 72. NanoSomiX Major Business
Table 73. NanoSomiX Exosome Detection and Diagnosis Product and Services
Table 74. NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. NanoSomiX Recent Developments/Updates
Table 76. NanoSomiX Competitive Strengths & Weaknesses
Table 77. Miltenyi Biotech Basic Information, Area Served and Competitors
Table 78. Miltenyi Biotech Major Business
Table 79. Miltenyi Biotech Exosome Detection and Diagnosis Product and Services
Table 80. Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Miltenyi Biotech Recent Developments/Updates
Table 82. Miltenyi Biotech Competitive Strengths & Weaknesses
Table 83. Norgen Biotek Basic Information, Area Served and Competitors
Table 84. Norgen Biotek Major Business
Table 85. Norgen Biotek Exosome Detection and Diagnosis Product and Services
Table 86. Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Norgen Biotek Recent Developments/Updates
Table 88. Norgen Biotek Competitive Strengths & Weaknesses
Table 89. AMSBio Basic Information, Area Served and Competitors
Table 90. AMSBio Major Business
Table 91. AMSBio Exosome Detection and Diagnosis Product and Services
Table 92. AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. AMSBio Recent Developments/Updates
Table 94. AMSBio Competitive Strengths & Weaknesses
Table 95. Aethlon Medical Basic Information, Area Served and Competitors
Table 96. Aethlon Medical Major Business
Table 97. Aethlon Medical Exosome Detection and Diagnosis Product and Services
Table 98. Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Aethlon Medical Recent Developments/Updates
Table 100. Aethlon Medical Competitive Strengths & Weaknesses
Table 101. Anjarium Biosciences Basic Information, Area Served and Competitors
Table 102. Anjarium Biosciences Major Business
Table 103. Anjarium Biosciences Exosome Detection and Diagnosis Product and Services
Table 104. Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Anjarium Biosciences Recent Developments/Updates
Table 106. Anjarium Biosciences Competitive Strengths & Weaknesses
Table 107. Ciloa Basic Information, Area Served and Competitors
Table 108. Ciloa Major Business
Table 109. Ciloa Exosome Detection and Diagnosis Product and Services
Table 110. Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Ciloa Recent Developments/Updates
Table 112. Ciloa Competitive Strengths & Weaknesses
Table 113. InnovaPrep Basic Information, Area Served and Competitors
Table 114. InnovaPrep Major Business
Table 115. InnovaPrep Exosome Detection and Diagnosis Product and Services
Table 116. InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. InnovaPrep Recent Developments/Updates
Table 118. InnovaPrep Competitive Strengths & Weaknesses
Table 119. Creative Medical Technologies Basic Information, Area Served and Competitors
Table 120. Creative Medical Technologies Major Business
Table 121. Creative Medical Technologies Exosome Detection and Diagnosis Product and Services
Table 122. Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Creative Medical Technologies Recent Developments/Updates
Table 124. Creative Medical Technologies Competitive Strengths & Weaknesses
Table 125. ILIAS Biologics Basic Information, Area Served and Competitors
Table 126. ILIAS Biologics Major Business
Table 127. ILIAS Biologics Exosome Detection and Diagnosis Product and Services
Table 128. ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. ILIAS Biologics Recent Developments/Updates
Table 130. ILIAS Biologics Competitive Strengths & Weaknesses
Table 131. Unchained Labs Basic Information, Area Served and Competitors
Table 132. Unchained Labs Major Business
Table 133. Unchained Labs Exosome Detection and Diagnosis Product and Services
Table 134. Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Unchained Labs Recent Developments/Updates
Table 136. Unchained Labs Competitive Strengths & Weaknesses
Table 137. Rion Basic Information, Area Served and Competitors
Table 138. Rion Major Business
Table 139. Rion Exosome Detection and Diagnosis Product and Services
Table 140. Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Rion Recent Developments/Updates
Table 142. Rion Competitive Strengths & Weaknesses
Table 143. Cell Guidance System Basic Information, Area Served and Competitors
Table 144. Cell Guidance System Major Business
Table 145. Cell Guidance System Exosome Detection and Diagnosis Product and Services
Table 146. Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Cell Guidance System Recent Developments/Updates
Table 148. Cell Guidance System Competitive Strengths & Weaknesses
Table 149. INOVIQ Basic Information, Area Served and Competitors
Table 150. INOVIQ Major Business
Table 151. INOVIQ Exosome Detection and Diagnosis Product and Services
Table 152. INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. INOVIQ Recent Developments/Updates
Table 154. INOVIQ Competitive Strengths & Weaknesses
Table 155. Danaher Basic Information, Area Served and Competitors
Table 156. Danaher Major Business
Table 157. Danaher Exosome Detection and Diagnosis Product and Services
Table 158. Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. Danaher Recent Developments/Updates
Table 160. Danaher Competitive Strengths & Weaknesses
Table 161. Exopharm Basic Information, Area Served and Competitors
Table 162. Exopharm Major Business
Table 163. Exopharm Exosome Detection and Diagnosis Product and Services
Table 164. Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. Exopharm Recent Developments/Updates
Table 166. Exopharm Competitive Strengths & Weaknesses
Table 167. Everzom Basic Information, Area Served and Competitors
Table 168. Everzom Major Business
Table 169. Everzom Exosome Detection and Diagnosis Product and Services
Table 170. Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. Everzom Recent Developments/Updates
Table 172. Everzom Competitive Strengths & Weaknesses
Table 173. RoosterBio Basic Information, Area Served and Competitors
Table 174. RoosterBio Major Business
Table 175. RoosterBio Exosome Detection and Diagnosis Product and Services
Table 176. RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. RoosterBio Recent Developments/Updates
Table 178. Creative Biolabs Basic Information, Area Served and Competitors
Table 179. Creative Biolabs Major Business
Table 180. Creative Biolabs Exosome Detection and Diagnosis Product and Services
Table 181. Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 182. Global Key Players of Exosome Detection and Diagnosis Upstream (Raw Materials)
Table 183. Exosome Detection and Diagnosis Typical Customers
LIST OF FIGURE
Figure 1. Exosome Detection and Diagnosis Picture
Figure 2. World Exosome Detection and Diagnosis Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Exosome Detection and Diagnosis Total Market Size (2019-2030) & (USD Million)
Figure 4. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 13. Exosome Detection and Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 16. World Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 18. China Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 23. India Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Exosome Detection and Diagnosis by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosome Detection and Diagnosis Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosome Detection and Diagnosis Markets in 2023
Figure 27. United States VS China: Exosome Detection and Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Exosome Detection and Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Exosome Detection and Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Exosome Detection and Diagnosis Market Size Market Share by Type in 2023
Figure 31. Kits & Reagents
Figure 32. Instruments
Figure 33. Services
Figure 34. World Exosome Detection and Diagnosis Market Size Market Share by Type (2019-2030)
Figure 35. World Exosome Detection and Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Exosome Detection and Diagnosis Market Size Market Share by Application in 2023
Figure 37. Cancers
Figure 38. Neurodegenerative Diseases
Figure 39. Cardiovascular Diseases
Figure 40. Infectious Diseases
Figure 41. Other
Figure 42. Exosome Detection and Diagnosis Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
Table 1. World Exosome Detection and Diagnosis Revenue by Region (2019, 2023 and 2030) & (USD Million), (by Headquarter Location)
Table 2. World Exosome Detection and Diagnosis Revenue by Region (2019-2024) & (USD Million), (by Headquarter Location)
Table 3. World Exosome Detection and Diagnosis Revenue by Region (2025-2030) & (USD Million), (by Headquarter Location)
Table 4. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019-2024), (by Headquarter Location)
Table 5. World Exosome Detection and Diagnosis Revenue Market Share by Region (2025-2030), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Exosome Detection and Diagnosis Consumption Value Growth Rate Forecast by Region (2019 & 2023 & 2030) & (USD Million)
Table 8. World Exosome Detection and Diagnosis Consumption Value by Region (2019-2024) & (USD Million)
Table 9. World Exosome Detection and Diagnosis Consumption Value Forecast by Region (2025-2030) & (USD Million)
Table 10. World Exosome Detection and Diagnosis Revenue by Player (2019-2024) & (USD Million)
Table 11. Revenue Market Share of Key Exosome Detection and Diagnosis Players in 2023
Table 12. World Exosome Detection and Diagnosis Industry Rank of Major Player, Based on Revenue in 2023
Table 13. Global Exosome Detection and Diagnosis Company Evaluation Quadrant
Table 14. Head Office of Key Exosome Detection and Diagnosis Player
Table 15. Exosome Detection and Diagnosis Market: Company Product Type Footprint
Table 16. Exosome Detection and Diagnosis Market: Company Product Application Footprint
Table 17. Exosome Detection and Diagnosis Mergers & Acquisitions Activity
Table 18. United States VS China Exosome Detection and Diagnosis Market Size Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 19. United States VS China Exosome Detection and Diagnosis Consumption Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 20. United States Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
Table 21. United States Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 22. United States Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 23. China Based Exosome Detection and Diagnosis Companies, Headquarters (Province, Country)
Table 24. China Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 25. China Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 26. Rest of World Based Exosome Detection and Diagnosis Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Exosome Detection and Diagnosis Revenue, (2019-2024) & (USD Million)
Table 28. Rest of World Based Companies Exosome Detection and Diagnosis Revenue Market Share (2019-2024)
Table 29. World Exosome Detection and Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
Table 30. World Exosome Detection and Diagnosis Market Size by Type (2019-2024) & (USD Million)
Table 31. World Exosome Detection and Diagnosis Market Size by Type (2025-2030) & (USD Million)
Table 32. World Exosome Detection and Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
Table 33. World Exosome Detection and Diagnosis Market Size by Application (2019-2024) & (USD Million)
Table 34. World Exosome Detection and Diagnosis Market Size by Application (2025-2030) & (USD Million)
Table 35. Thermo Fisher Scientific Basic Information, Area Served and Competitors
Table 36. Thermo Fisher Scientific Major Business
Table 37. Thermo Fisher Scientific Exosome Detection and Diagnosis Product and Services
Table 38. Thermo Fisher Scientific Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 39. Thermo Fisher Scientific Recent Developments/Updates
Table 40. Thermo Fisher Scientific Competitive Strengths & Weaknesses
Table 41. Bio-Techne Basic Information, Area Served and Competitors
Table 42. Bio-Techne Major Business
Table 43. Bio-Techne Exosome Detection and Diagnosis Product and Services
Table 44. Bio-Techne Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 45. Bio-Techne Recent Developments/Updates
Table 46. Bio-Techne Competitive Strengths & Weaknesses
Table 47. System Biosciences Basic Information, Area Served and Competitors
Table 48. System Biosciences Major Business
Table 49. System Biosciences Exosome Detection and Diagnosis Product and Services
Table 50. System Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 51. System Biosciences Recent Developments/Updates
Table 52. System Biosciences Competitive Strengths & Weaknesses
Table 53. QIAGEN Basic Information, Area Served and Competitors
Table 54. QIAGEN Major Business
Table 55. QIAGEN Exosome Detection and Diagnosis Product and Services
Table 56. QIAGEN Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 57. QIAGEN Recent Developments/Updates
Table 58. QIAGEN Competitive Strengths & Weaknesses
Table 59. Lonza Basic Information, Area Served and Competitors
Table 60. Lonza Major Business
Table 61. Lonza Exosome Detection and Diagnosis Product and Services
Table 62. Lonza Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 63. Lonza Recent Developments/Updates
Table 64. Lonza Competitive Strengths & Weaknesses
Table 65. NX Pharmagen Basic Information, Area Served and Competitors
Table 66. NX Pharmagen Major Business
Table 67. NX Pharmagen Exosome Detection and Diagnosis Product and Services
Table 68. NX Pharmagen Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 69. NX Pharmagen Recent Developments/Updates
Table 70. NX Pharmagen Competitive Strengths & Weaknesses
Table 71. NanoSomiX Basic Information, Area Served and Competitors
Table 72. NanoSomiX Major Business
Table 73. NanoSomiX Exosome Detection and Diagnosis Product and Services
Table 74. NanoSomiX Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 75. NanoSomiX Recent Developments/Updates
Table 76. NanoSomiX Competitive Strengths & Weaknesses
Table 77. Miltenyi Biotech Basic Information, Area Served and Competitors
Table 78. Miltenyi Biotech Major Business
Table 79. Miltenyi Biotech Exosome Detection and Diagnosis Product and Services
Table 80. Miltenyi Biotech Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 81. Miltenyi Biotech Recent Developments/Updates
Table 82. Miltenyi Biotech Competitive Strengths & Weaknesses
Table 83. Norgen Biotek Basic Information, Area Served and Competitors
Table 84. Norgen Biotek Major Business
Table 85. Norgen Biotek Exosome Detection and Diagnosis Product and Services
Table 86. Norgen Biotek Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 87. Norgen Biotek Recent Developments/Updates
Table 88. Norgen Biotek Competitive Strengths & Weaknesses
Table 89. AMSBio Basic Information, Area Served and Competitors
Table 90. AMSBio Major Business
Table 91. AMSBio Exosome Detection and Diagnosis Product and Services
Table 92. AMSBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 93. AMSBio Recent Developments/Updates
Table 94. AMSBio Competitive Strengths & Weaknesses
Table 95. Aethlon Medical Basic Information, Area Served and Competitors
Table 96. Aethlon Medical Major Business
Table 97. Aethlon Medical Exosome Detection and Diagnosis Product and Services
Table 98. Aethlon Medical Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 99. Aethlon Medical Recent Developments/Updates
Table 100. Aethlon Medical Competitive Strengths & Weaknesses
Table 101. Anjarium Biosciences Basic Information, Area Served and Competitors
Table 102. Anjarium Biosciences Major Business
Table 103. Anjarium Biosciences Exosome Detection and Diagnosis Product and Services
Table 104. Anjarium Biosciences Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 105. Anjarium Biosciences Recent Developments/Updates
Table 106. Anjarium Biosciences Competitive Strengths & Weaknesses
Table 107. Ciloa Basic Information, Area Served and Competitors
Table 108. Ciloa Major Business
Table 109. Ciloa Exosome Detection and Diagnosis Product and Services
Table 110. Ciloa Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 111. Ciloa Recent Developments/Updates
Table 112. Ciloa Competitive Strengths & Weaknesses
Table 113. InnovaPrep Basic Information, Area Served and Competitors
Table 114. InnovaPrep Major Business
Table 115. InnovaPrep Exosome Detection and Diagnosis Product and Services
Table 116. InnovaPrep Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 117. InnovaPrep Recent Developments/Updates
Table 118. InnovaPrep Competitive Strengths & Weaknesses
Table 119. Creative Medical Technologies Basic Information, Area Served and Competitors
Table 120. Creative Medical Technologies Major Business
Table 121. Creative Medical Technologies Exosome Detection and Diagnosis Product and Services
Table 122. Creative Medical Technologies Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 123. Creative Medical Technologies Recent Developments/Updates
Table 124. Creative Medical Technologies Competitive Strengths & Weaknesses
Table 125. ILIAS Biologics Basic Information, Area Served and Competitors
Table 126. ILIAS Biologics Major Business
Table 127. ILIAS Biologics Exosome Detection and Diagnosis Product and Services
Table 128. ILIAS Biologics Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 129. ILIAS Biologics Recent Developments/Updates
Table 130. ILIAS Biologics Competitive Strengths & Weaknesses
Table 131. Unchained Labs Basic Information, Area Served and Competitors
Table 132. Unchained Labs Major Business
Table 133. Unchained Labs Exosome Detection and Diagnosis Product and Services
Table 134. Unchained Labs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 135. Unchained Labs Recent Developments/Updates
Table 136. Unchained Labs Competitive Strengths & Weaknesses
Table 137. Rion Basic Information, Area Served and Competitors
Table 138. Rion Major Business
Table 139. Rion Exosome Detection and Diagnosis Product and Services
Table 140. Rion Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 141. Rion Recent Developments/Updates
Table 142. Rion Competitive Strengths & Weaknesses
Table 143. Cell Guidance System Basic Information, Area Served and Competitors
Table 144. Cell Guidance System Major Business
Table 145. Cell Guidance System Exosome Detection and Diagnosis Product and Services
Table 146. Cell Guidance System Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 147. Cell Guidance System Recent Developments/Updates
Table 148. Cell Guidance System Competitive Strengths & Weaknesses
Table 149. INOVIQ Basic Information, Area Served and Competitors
Table 150. INOVIQ Major Business
Table 151. INOVIQ Exosome Detection and Diagnosis Product and Services
Table 152. INOVIQ Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 153. INOVIQ Recent Developments/Updates
Table 154. INOVIQ Competitive Strengths & Weaknesses
Table 155. Danaher Basic Information, Area Served and Competitors
Table 156. Danaher Major Business
Table 157. Danaher Exosome Detection and Diagnosis Product and Services
Table 158. Danaher Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 159. Danaher Recent Developments/Updates
Table 160. Danaher Competitive Strengths & Weaknesses
Table 161. Exopharm Basic Information, Area Served and Competitors
Table 162. Exopharm Major Business
Table 163. Exopharm Exosome Detection and Diagnosis Product and Services
Table 164. Exopharm Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 165. Exopharm Recent Developments/Updates
Table 166. Exopharm Competitive Strengths & Weaknesses
Table 167. Everzom Basic Information, Area Served and Competitors
Table 168. Everzom Major Business
Table 169. Everzom Exosome Detection and Diagnosis Product and Services
Table 170. Everzom Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 171. Everzom Recent Developments/Updates
Table 172. Everzom Competitive Strengths & Weaknesses
Table 173. RoosterBio Basic Information, Area Served and Competitors
Table 174. RoosterBio Major Business
Table 175. RoosterBio Exosome Detection and Diagnosis Product and Services
Table 176. RoosterBio Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 177. RoosterBio Recent Developments/Updates
Table 178. Creative Biolabs Basic Information, Area Served and Competitors
Table 179. Creative Biolabs Major Business
Table 180. Creative Biolabs Exosome Detection and Diagnosis Product and Services
Table 181. Creative Biolabs Exosome Detection and Diagnosis Revenue, Gross Margin and Market Share (2019-2024) & (USD Million)
Table 182. Global Key Players of Exosome Detection and Diagnosis Upstream (Raw Materials)
Table 183. Exosome Detection and Diagnosis Typical Customers
LIST OF FIGURE
Figure 1. Exosome Detection and Diagnosis Picture
Figure 2. World Exosome Detection and Diagnosis Total Market Size: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Exosome Detection and Diagnosis Total Market Size (2019-2030) & (USD Million)
Figure 4. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019, 2023 and 2030) & (USD Million) , (by Headquarter Location)
Figure 5. World Exosome Detection and Diagnosis Revenue Market Share by Region (2019-2030), (by Headquarter Location)
Figure 6. United States Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 7. China Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 8. Europe Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 9. Japan Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 10. South Korea Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 11. ASEAN Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 12. India Based Company Exosome Detection and Diagnosis Revenue (2019-2030) & (USD Million)
Figure 13. Exosome Detection and Diagnosis Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 16. World Exosome Detection and Diagnosis Consumption Value Market Share by Region (2019-2030)
Figure 17. United States Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 18. China Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 19. Europe Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 20. Japan Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 21. South Korea Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 22. ASEAN Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 23. India Exosome Detection and Diagnosis Consumption Value (2019-2030) & (USD Million)
Figure 24. Producer Shipments of Exosome Detection and Diagnosis by Player Revenue ($MM) and Market Share (%): 2023
Figure 25. Global Four-firm Concentration Ratios (CR4) for Exosome Detection and Diagnosis Markets in 2023
Figure 26. Global Four-firm Concentration Ratios (CR8) for Exosome Detection and Diagnosis Markets in 2023
Figure 27. United States VS China: Exosome Detection and Diagnosis Revenue Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Exosome Detection and Diagnosis Consumption Value Market Share Comparison (2019 & 2023 & 2030)
Figure 29. World Exosome Detection and Diagnosis Market Size by Type, (USD Million), 2019 & 2023 & 2030
Figure 30. World Exosome Detection and Diagnosis Market Size Market Share by Type in 2023
Figure 31. Kits & Reagents
Figure 32. Instruments
Figure 33. Services
Figure 34. World Exosome Detection and Diagnosis Market Size Market Share by Type (2019-2030)
Figure 35. World Exosome Detection and Diagnosis Market Size by Application, (USD Million), 2019 & 2023 & 2030
Figure 36. World Exosome Detection and Diagnosis Market Size Market Share by Application in 2023
Figure 37. Cancers
Figure 38. Neurodegenerative Diseases
Figure 39. Cardiovascular Diseases
Figure 40. Infectious Diseases
Figure 41. Other
Figure 42. Exosome Detection and Diagnosis Industrial Chain
Figure 43. Methodology
Figure 44. Research Process and Data Source
